Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 251

Similar articles for PubMed (Select 22162411)

1.

Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center.

Barthélémy O, Silvain J, Brieger D, Mercadier A, Lancar R, Bellemain-Appaix A, Beygui F, Collet JP, Costagliola D, Montalescot G.

Catheter Cardiovasc Interv. 2012 Jan 1;79(1):104-12. doi: 10.1002/ccd.23164. Epub 2011 Dec 8.

PMID:
22162411
2.

Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry.

Siudak Z, Zawislak B, Dziewierz A, Rakowski T, Jakala J, Bartus S, Noworolnik B, Zasada W, Dubiel JS, Dudek D.

Coron Artery Dis. 2010 Aug;21(5):292-7. doi: 10.1097/MCA.0b013e32833aa6d1.

PMID:
20453640
3.

Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction.

Vranckx P, Campo G, Anselmi M, Bolognese L, Colangelo S, Biondi-Zoccai G, Moreno R, Piva T, Favero L, Prati F, Nazzaro M, Díaz Fernández JF, Ferrari R, Valgimigli M; Multicenter Evaluation of Single High-Dose Bolus Tirofiban vs. Abciximab with Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study.

EuroIntervention. 2012 May 15;8(1):71-8. doi: 10.4244/EIJV8I1A12.

4.

Trans-radial approach for catheterisation in non-ST segment elevation acute coronary syndrome: an analysis of major bleeding complications in the ABOARD Study.

Cayla G, Silvain J, Barthelemy O, Connor S', Payot L, Bellemain-Appaix A, Beygui F, Aout M, Collet JP, Vicaut E, Montalescot G; ABOARD investigators.

Heart. 2011 Jun;97(11):887-91. doi: 10.1136/hrt.2010.220137. Epub 2011 Mar 18.

PMID:
21421600
5.

Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.

Bagur R, Bertrand OF, Rodés-Cabau J, Larose E, Rinfret S, Nguyen CM, Noel B, Larochellière RD, Poirier P, Costerousse O, Roy L.

Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1010-6. doi: 10.1002/ccd.22235.

PMID:
19753635
6.

Bleeding outcomes after routine transradial primary angioplasty for acute myocardial infarction using eptifibatide and unfractionated heparin: a single-center experience following the HORIZONS-AMI trial.

Moody WE, Chue CD, Ludman PF, Chan YK, Narayan G, Millington JM, Townend JN, Doshi SN.

Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E138-47. doi: 10.1002/ccd.24703. Epub 2013 Apr 8.

PMID:
23074143
7.

Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction.

Hermanides RS, Ottervanger JP, Dambrink JH, de Boer MJ, Hoorntje JC, Gosselink AT, Suryapranata H, van 't Hof AW.

EuroIntervention. 2010 May;6(1):106-11. doi: 10.4244/.

PMID:
20542805
8.

Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?

Mamas MA, Ratib K, Routledge H, Neyses L, Fraser DG, de Belder M, Ludman PF, Nolan J; British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.

JACC Cardiovasc Interv. 2013 Jul;6(7):698-706. doi: 10.1016/j.jcin.2013.03.011. Epub 2013 Jun 14.

9.

Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals.

Herrmann HC, Lu J, Brodie BR, Armstrong PW, Montalescot G, Betriu A, Neuman FJ, Effron MB, Barnathan ES, Topol EJ, Ellis SG; FINESSE Investigators.

JACC Cardiovasc Interv. 2009 Oct;2(10):917-24. doi: 10.1016/j.jcin.2009.06.018.

10.

Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.

Denktas AE, Athar H, Henry TD, Larson DM, Simons M, Chan RS, Niles NW, Thiele H, Schuler G, Ahn C, Sdringola S, Anderson HV, McKay RG, Smalling RW.

JACC Cardiovasc Interv. 2008 Oct;1(5):504-10. doi: 10.1016/j.jcin.2008.06.009.

11.

Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention.

Verheugt FW, Steinhubl SR, Hamon M, Darius H, Steg PG, Valgimigli M, Marso SP, Rao SV, Gershlick AH, Lincoff AM, Mehran R, Stone GW.

JACC Cardiovasc Interv. 2011 Feb;4(2):191-7. doi: 10.1016/j.jcin.2010.10.011.

12.

Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.

De Carlo M, Borelli G, Gistri R, Ciabatti N, Mazzoni A, Arena M, Petronio AS.

Catheter Cardiovasc Interv. 2009 Sep 1;74(3):408-15. doi: 10.1002/ccd.22008.

PMID:
19360863
13.

The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis from the National Cardiovascular Data Registry (2007 to 2011).

Baklanov DV, Kaltenbach LA, Marso SP, Subherwal SS, Feldman DN, Garratt KN, Curtis JP, Messenger JC, Rao SV.

J Am Coll Cardiol. 2013 Jan 29;61(4):420-6. doi: 10.1016/j.jacc.2012.10.032. Epub 2012 Dec 19. Erratum in: J Am Coll Cardiol. 2013 Apr 2;61(13):1469.

14.

Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.

Dörler J, Edlinger M, Alber HF, Altenberger J, Benzer W, Grimm G, Huber K, Pachinger O, Schuchlenz H, Siostrzonek P, Zenker G, Weidinger F; Austrian Acute PCI Investigators.

Eur Heart J. 2011 Dec;32(23):2954-61. doi: 10.1093/eurheartj/ehr360. Epub 2011 Sep 14.

15.

Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005.

Doyle BJ, Ting HH, Bell MR, Lennon RJ, Mathew V, Singh M, Holmes DR, Rihal CS.

JACC Cardiovasc Interv. 2008 Apr;1(2):202-9. doi: 10.1016/j.jcin.2007.12.006.

16.

European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab -- EUROTRANSFER Registry.

Dudek D, Siudak Z, Janzon M, Birkemeyer R, Aldama-Lopez G, Lettieri C, Janus B, Wisniewski A, Berti S, Olivari Z, Rakowski T, Partyka L, Goedicke J, Zmudka K; EUROTRANSFER Registry Investigators.

Am Heart J. 2008 Dec;156(6):1147-54. doi: 10.1016/j.ahj.2008.08.004. Epub 2008 Oct 19.

PMID:
19033011
18.

Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention.

Brieger D, Collet JP, Silvain J, Landivier A, Barthélémy O, Beygui F, Bellemain-Appaix A, Mercadier A, Choussat R, Vignolles N, Costagliola D, Montalescot G.

Catheter Cardiovasc Interv. 2011 Feb 1;77(2):182-90. doi: 10.1002/ccd.22674.

PMID:
20578166
19.

A regional pharmacoinvasive PCI strategy incorporating selected bleeding avoidance strategies.

Chava S, Raza S, El-Haddad MA, Priest J, Ashikaga T, Dauerman HL.

Coron Artery Dis. 2015 Jan;26(1):30-6. doi: 10.1097/MCA.0000000000000177.

PMID:
25279566
20.

Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction.

Nikolsky E, Sadeghi HM, Effron MB, Mehran R, Lansky AJ, Na Y, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Stuckey TD, Turco M, Carroll JD, Grines CL, Stone GW.

Am J Cardiol. 2005 Aug 15;96(4):474-81.

PMID:
16098296
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk